| Literature DB >> 26694333 |
Mingzhi Zhu1,2, Xia Dong3, Mingquan Guo4,5.
Abstract
Duchesnea indica (D. indica) is an important traditional Chinese medicine, and has long been clinically used to treat cancer in Asian countries. It has been described previously as a rich source of phenolic compounds with a broad array of diversified structures, which are the major active ingredients. However, an accurate and complete phenolic profiling has not been determined yet. In the present work, the total phenolic compounds in crude extracts from D. indica were enriched and fractionated over a macroporous resin column, then identified by HPLC-ESI-MS/MS and ESI-IT-MS (ion trap MS). A total of 27 phenolic compounds were identified in D. indica, of which 21 compounds were identified for the first time. These 27 phenolic compounds encompassing four phenolic groups, including ellagitannins, ellagic acid and ellagic acid glycosides, hydroxybenzoic acid and hydroxycinnamic acid derivatives, and flavonols, were then successfully quantified using peak areas against those of the corresponding standards with good linearity (R² > 0.998) in the range of the tested concentrations. As a result, the contents of individual phenolic compounds varied from 6.69 mg per 100 g dry weight (DW) for ellagic acid to 71.36 mg per 100 g DW for brevifolin carboxylate. Not only did this study provide the first phenolic profiling of D. indica, but both the qualitative identification and the subsequent quantitative analysis of 27 phenolic compounds from D. indica should provide a good basis for future exploration of this valuable medicinal plant.Entities:
Keywords: Duchesnea indica; HPLC; mass spectrometry; phenolic profiling
Mesh:
Substances:
Year: 2015 PMID: 26694333 PMCID: PMC6332051 DOI: 10.3390/molecules201219859
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1The HPLC profiles of phenolic compounds in fraction I from D. indica recorded at 260 nm (A) and 360 nm (B). The peak numbers correspond to those used in Table 1.
Qualitative and quantitative analysis of 27 phenolic compounds in fraction I from D. indica.
| Peak | tR (min) a | [M − H]− ( | MS/MS Ions ( | MS3 Ions ( | Compounds | Contents (mg/100 g DW) |
|---|---|---|---|---|---|---|
| 1 | 12.1 | 783 | 481, 301 b | 257, 229, 185 | bis-HHDP-glucose c | 29.10 |
| 2 | 15.8 | 783 | 481, 301 b | 257, 229, 185 | bis-HHDP-glucose c | 33.85 |
| 3 | 17.1 | 783 | 481, 301 b | 257, 229, 185 | bis-HHDP-glucose c | 15.90 |
| 4 | 18.8 | 337 | 191, 173, 163, 155 | 15.97 | ||
| 5 | 20.8 | 633 | 481, 301 b | 257, 229, 185 | galloyl-HHDP-glucose c | 25.33 |
| 6 | 22.8 | 291 | 247, 219, 191 | brevifolin carboxylate d | 71.36 | |
| 7 | 24.2 | 179 | 135, 134 | caffeic acid d | 14.74 | |
| 8 | 26.2 | 297 | 179, 161, 135, 117 | caffeic acid derivate c | 17.64 | |
| 9 | 26.9 | 637 | 461, 285 b | 93 | kaempferol | 15.04 |
| 10 | 28.2 | 337 | 191, 173, 163, 155 | 14.74 | ||
| 11 | 29.7 | 783 | 633, 481, 301 b | 257, 229, 185 | bis-HHDP-glucose c | 13.20 |
| 12 | 30.5 | 783 | 633, 481, 301 b | 257, 229, 185 | bis-HHDP-glucose c | 11.93 |
| 13 | 32.3 | 247 | 219, 191 | Brevifolin c | 21.71 | |
| 14 | 33.6 | 935 | 633, 301 b | 257, 229, 185 | galloyl-bis-HHDP-glucose c | 16.17 |
| 15 | 34.4 | 305 | 273, 245, 229 | methyl brevifolin carboxylate | 43.56 | |
| 16 | 35.5 | 563 | 503, 473, 383, 353 | apigenin 6- | 10.13 | |
| 17 | 36.3 | 783 | 633, 481, 301 b | 257, 229, 185 | bis-HHDP-glucose c | 26.24 |
| 18 | 37.7 | 783 | 633, 481, 301 b | 257, 229, 185 | bis-HHDP-glucose c | 14.87 |
| 19 | 40.6 | 433 | 301 b | 257, 229, 185 | ellagic acid pentoside c | 11.18 |
| 20 | 42.5 | 433 | 301 b | 257, 229, 185 | ellagic acid pentoside c | 12.64 |
| 21 | 43.8 | 301 | 257, 229, 185 | ellagic acid d | 6.69 | |
| 22 | 45.4 | 935 | 633, 301 b | 257, 229, 185 | galloyl-bis-HHDP-glucose c | 48.89 |
| 23 | 47.2 | 935 | 633, 301 b | 257, 229, 185 | galloyl-bis-HHDP-glucose c | 17.50 |
| 24 | 48.6 | 477 | 301 b, 179, 151 | 179 151 | quercetin | 10.06 |
| 25 | 53.9 | 593 | 285 b | 93 | kaempferol | 12.15 |
| 26 | 56.7 | 447 | 284, 255 b, 227 | 93 | kaempferol 3- | 17.55 |
| 27 | 57.6 | 461 | 285 b | 93 | kaempferol | 25.45 |
| Total ellagitannins | 252.98 | |||||
| Total ellagic acid and ellagic acid glycosides | 30.52 | |||||
| Total hydroxybenzoic acid and hydroxycinnamic acid derivatives | 199.73 | |||||
| Total flavonols | 90.39 | |||||
a Peak numbers and retention times refer to Figure 1; b These ions were further fragmented to yield the MS3 data; c Identified based on the published literature; d Identified with the corresponding standards.
Figure 2The MS/MS spectra of the standard of corilagin and some representative ellagitannins in D. indica: (A) corilagin; (B) peak 1; (C) peak 5; (D) peak 14. The peak numbers correspond to those used in Table 1.
Figure 3The MS/MS spectra of representative ellagic acid glycoside ((A) peak 19), hydroxybenzoic acid derivative ((B) peak 4), hydroxycinnamic acid derivative ((C) peak 13), and flavonol ((D) peak 9). The peak numbers correspond to those used in Table 1.
Liner equation, correlation coefficients, limits of detection, and limits of quantification of five representative phenolic standards.
| Compounds | Liner Equation (μg/mL) | R2 | Linear Range (μg/mL) | LOD a (μg/mL) | LOQ b (μg/mL) |
|---|---|---|---|---|---|
| Caffeic acid | y = 8.56x − 34.67 | 0.9997 | 0.94–588 | 0.17 | 0.57 |
| Apigenin 6- | y = 16.38x − 37.08 | 0.9998 | 0.69–430 | 0.07 | 0.24 |
| Ellagic acid | y = 14.53x − 25.08 | 0.9982 | 0.90–560 | 2.24 | 7.47 |
| Corilagin | y = 17.91x − 59.47 | 0.9997 | 0.82–510 | 0.19 | 0.65 |
| Kaempferol 3- | y = 21.39x − 59.04 | 0.9998 | 0.80–500 | 0.06 | 0.21 |
a LOD = limit of detection, S/N = 3; b LOQ = limit of quantitation, S/N = 10.